BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20175005)

  • 21. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
    Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE
    Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome.
    Brugière O; Thabut G; Mal H; Marceau A; Dauriat G; Marrash-Chahla R; Castier Y; Lesèche G; Colombat M; Fournier M
    Eur Respir J; 2005 May; 25(5):813-9. PubMed ID: 15863637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients.
    Hall DJ; Baz M; Daniels MJ; Staples ED; Klodell CT; Moldawer LL; Beaver TM
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):603-7. PubMed ID: 22815323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS).
    Fisher AJ; Wardle J; Dark JH; Corris PA
    J Heart Lung Transplant; 2002 Nov; 21(11):1206-12. PubMed ID: 12431494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
    Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchiolitis obliterans syndrome leads to a functional deterioration of the acinus post lung transplant.
    Thompson BR; Hodgson YM; Kotsimbos T; Liakakos P; Ellis MJ; Snell GI; Verbanck S
    Thorax; 2014 May; 69(5):487-8. PubMed ID: 24212890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome.
    Fakhro M; Broberg E; Algotsson L; Hansson L; Koul B; Gustafsson R; Wierup P; Ingemansson R; Lindstedt S
    J Cardiothorac Surg; 2017 Nov; 12(1):100. PubMed ID: 29178919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
    Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
    Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase.
    Gabbay E; Walters EH; Orsida B; Whitford H; Ward C; Kotsimbos TC; Snell GI; Williams TJ
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2182-7. PubMed ID: 11112135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are we near to an effective drug treatment for bronchiolitis obliterans?
    Verleden GM; Vos R; Dupont L; Van Raemdonck DE; Vanaudenaerde BM; Verleden SE
    Expert Opin Pharmacother; 2014 Oct; 15(15):2117-20. PubMed ID: 25154562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchiolitis obliterans syndrome development in lung transplantation patients.
    Parada MT; Alba A; Sepúlveda C
    Transplant Proc; 2010; 42(1):331-2. PubMed ID: 20172344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive investigations for the early detection of chronic airways dysfunction following lung transplantation.
    Cook RC; Fradet G; Müller NL; Worsely DF; Ostrow D; Levy RD
    Can Respir J; 2003 Mar; 10(2):76-83. PubMed ID: 12687027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.
    Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ
    Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Barbosa EJM; Lanclus M; Vos W; Van Holsbeke C; De Backer W; De Backer J; Lee J
    Acad Radiol; 2018 Sep; 25(9):1201-1212. PubMed ID: 29472146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychiatric Predictors of Long-term Transplant-Related Outcomes in Lung Transplant Recipients.
    Rosenberger EM; DiMartini AF; DeVito Dabbs AJ; Bermudez CA; Pilewski JM; Toyoda Y; Dew MA
    Transplantation; 2016 Jan; 100(1):239-47. PubMed ID: 26177087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bronchiolitis obliterans syndrome is not specific for bronchiolitis obliterans in pediatric lung transplant.
    Towe C; Chester Ogborn A; Ferkol T; Sweet S; Huddleston C; White F; Faro A
    J Heart Lung Transplant; 2015 Apr; 34(4):516-21. PubMed ID: 25499141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
    Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
    J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
    Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
    J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.